Published

02 May 25

Updated

14 Jun 26

Views

1.1k

Not Invested

Fair Value

US$96.5

Share price14 Jun

US$56.6241.3% undervalued

Loading

1Y2,383.33%

7D-20.77%

AXTI: Export Permit Uncertainty Will Challenge Margin Strength Moving Forward

AN

AnalystConsensusTarget

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published

02 May 25

Updated

14 Jun 26

Views

1.1k

Not Invested

Shared on 14 Jun 26

Fair value Increased 214%

AXTI: AI Capacity Expansion And Export Limits Will Balance Future Upside

Wall Street gets much more excited about AXT as AI-driven data center upgrades boost expectations for demand, and the company raises fresh funding to expand a key product line. But tighter export limits and the risk that AI orders come in unevenly could quickly test whether today’s optimism holds up.

38 views

Shared on 14 Apr 26

Fair value Increased 8.85%

AXTI: Export Permit Limits Will Continue To Restrain InP AI Upside

Analysts have raised AXT's fair value estimate from $28.25 to $30.75, reflecting updated views on higher potential P/E multiples, supported by expected InP growth and recent price target increases from several research firms. Analyst Commentary Recent research gives you a mixed but useful read on how the Street is thinking about AXT, with some focusing on long term InP growth potential and others highlighting nearer term execution risks and regulatory overhangs.

112 views

Shared on 03 Mar 26

Fair value Increased 197%

AXTI: InP Export Permit Constraints Will Undermine AI Demand Upside Potential

Narrative Update on AXT The analyst price targets for AXT have moved sharply higher, with recent updates ranging from $21 to $35. Analysts are factoring in higher fair value estimates and stronger InP growth expectations, despite ongoing export permit uncertainty.

79 views

Shared on 14 Dec 25

AXTI: New Export Permits Will Intensify Regulatory And Execution Downside Risks

Analysts have raised their price target on AXT by approximately $2.90 per share to around $7.00, citing improved revenue expectations after the company received new export permits that enable it to resume shipping indium phosphide substrates to additional customers. Analyst Commentary Analysts are updating their models ahead of upcoming quarterly results, reflecting the impact of newly granted export permits on AXT's near term revenue and margin profile.

44 views

Shared on 30 Nov 25

AXTI: Export Permit Reliance Will Heighten Downside Risks Amid Ongoing Uncertainty

Analysts have increased their price target for AXT to $7 from $4.10, citing higher anticipated revenues because the company recently obtained export permits that allow it to ship indium phosphide substrates to additional customers. Analyst Commentary Recent updates from the analyst community reflect a reassessment of AXT's growth prospects and financial outlook following the news about new export permits for indium phosphide substrates.

19 views

Shared on 16 Nov 25

Fair value Increased 67%

AXTI: Renewed Export Permits Will Influence Recovery Amid Regulatory Risks

Analysts have raised AXT's fair value estimate significantly from $5.70 to $9.50 per share, citing improved revenue assumptions following renewed export permits and a higher price target in recent research updates. Analyst Commentary Analyst reactions to AXT's recent developments have brought both optimism and caution regarding the company's future prospects and valuation.

46 views

Shared on 02 Nov 25

Fair value Increased 49%

The analyst price target for AXT has increased significantly from $3.82 to $5.70 per share, as analysts cite improved revenue growth expectations and recent export permit approvals as key drivers behind their revised outlook. Analyst Commentary Analyst sentiment regarding AXT has evolved in response to recent company developments, with notable optimism about future growth prospects.

8 views

Fair Value vs Share Price

US$96.5

vs US$56.6241.3% undervalued

57.5%

Revenue growth

37.6%

Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on AXT

Fair value estimate changes
Narrative and analyst updates
Key company announcements

Company analysis

High growth potential with mediocre balance sheet.

Market capUS$3.6b

PB13.3x

Estimated Growth44.5%

Dividend YieldN/A

CEO & management

Morris Young

CEO

11.9yrs

CEO Tenure

Designs, develops, manufactures, and distributes compound and single element semiconductor substrates.